EQ
USDEquillium Inc. Common Stock
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$0.351
Máximo
$0.390
Mínimo
$0.351
Volumen
0.22M
Fundamentos de la Empresa
Capitalización de Mercado
13.8M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.36M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
Leerink Partners Downgrades Equillium to Market Perform, Lowers Price Target to $1
Leerink Partners analyst Thomas Smith downgrades Equillium from Outperform to Market Perform and lowers the price target from $3 to $1.
Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease
Treatment with itolizumab did not improve complete or overall response rates at Day 29 Itolizumab achieved statistical significance in multiple secondary endpoints demonstrating compelling clinical benefit in
Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights
Announced topline data from the Phase 3 EQUATOR study in first-line acute graft-versus-host disease Breakthrough Therapy designation and meeting request to discuss potential for Accelerated Approval submitted to FDA,
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.